Irazu Oncology
PrivateLast Round
VC Round
Mar 4, 2025
Total Funding Raised
$2.6M
Momentum Score
75 /100
Company Overview
Irazu Oncology is a preclinical biotechnology company that develops cancer immunotherapies using its proprietary Outer Membrane Vesicles (OMV) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Irazu Oncology Comps
Public and private peers based on sector, stage, and business model.
Irazu Oncology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 4, 2025 | ||||
| Series A | Mar 4, 2025 | ||||
| Seed | Dec 19, 2023 |
Key People
Founding team and executive leadership
Irazu Oncology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Abell Foundation | Seed |
| Wexford SciTech Venture Fund | Seed |
| TEDCO | VC Round, Seed |
| University System of Maryland Momentum Fund | Seed |
| University of Maryland, Baltimore | Seed |
Irazu Oncology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Irazu Oncology's valuation, stock price, and market status.
